Diagnostic usefulness of bone marrow cultures in
patients with fever of unknown origin.
Suggested techniques for fecal occult blood testing
and interpretation in colorectal cancer screening.
Clinical laboratory test findings in patients with
chronic fatigue syndrome.
Pre operative laboratory evaluation.
A prospective multicenter evaluation of preoperative
hemostatic screening tests.
High dose intravenous immune globulins and the
response to splenectomy in patients with idiopathic thrombocytopenic pupura.
Platelet function defects associated with hemorrhage
or thrombosis.
Inherited coagulation disorders.
Disseminated intravenous coagulation – clinical
& laboratory diagnosis & assessment of therapeutic response.
Pathogenesis of cholestasis.
HCV – related chronic liver disease.
Cirrhosis of liver.
Pyogenic liver abscess.
Pancreatitis – pathological features.
Testing for breast ovarian cancer susceptibility.
Range of anti nuclear antibodies in healthy
individuals.
Test performance in systemic sclerosis.
Prostate cancer screening.
Suspicious thyroid cytologic findings.
Long term changes in nodular goiter.
Factors that predict malignant thyroid lesions when
fine needle aspiration is suspicious of malignancy.
Diagnosis of endocrine neoplasia.
Pathology of diabetic nephropathy.
Laboratory screening in suspected AIDS patients.
Diagnosis of herpes simplex encephalitis.
Microbiology and laboratory diagnosis of upper
respiratory tract infection.
Effect of isolated systolic hypertension on left
ventricular mass.
Pathology of adult respiratory distress syndrome.
Survival and prognostic factors in patients with
severe alcoholic hepatitis.
Pathological changes in fatty liver.
Cirrhotic findings in liver.
Pathogenesis of cholesterol gall stones.
Evaluation of pancreatic disease in laboratory.
Epidemiology,pathology,diagnosis and staging
techniques of pancreatic carcinoma.
Genetic testing for cancer risk.
Analysis of residual cancer after diagnostic breast
biopsy.
Immunohistochemical analysis of estrogen receptors in
breast carcinoma.
Guidelines for the use of tumor markers in breast and
colorectal cancer.